William Blair analyst Andy T. Hsieh initiates coverage on Kailera Therapeutics (NASDAQ: KLRA) with a Outperform rating.The analyst comments "Kailera ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE